XML 38 R28.htm IDEA: XBRL DOCUMENT v3.25.3
Revenue and Contract Acquisition Costs (Tables)
9 Months Ended
Sep. 30, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table summarizes the Company’s disaggregated revenue:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2025202420252024
U.S.
$497.1 $395.6 $1,352.0 $1,065.6 
International
202.1 137.9 540.2 381.4 
Total Omnipod products
699.2 533.5 1,892.2 1,447.0 
Drug Delivery7.1 10.3 32.2 27.1 
Total revenue$706.3 $543.9 $1,924.3 $1,474.1 
Schedules of Concentration of Risk
The percentages of total revenue for customers that represent 10% or more of total revenue were as follows:
Three Months Ended September 30,Nine Months Ended September 30,

2025202420252024
Distributor A28 %30 %27 %28 %
Distributor B26 %25 %26 %27 %
Distributor C
24 %19 %24 %22 %
The percentages of accounts receivable trade for customers that represent 10% or more of total accounts receivable trade were as follows:

September 30, 2025December 31, 2024
Distributor A33 %35 %
Distributor B21 %27 %
Distributor C
12 %15 %
Schedule of Deferred Revenue
Deferred revenue related to unsatisfied performance obligations was included in the following consolidated balance sheet accounts in the amounts shown:
(in millions)
September 30, 2025December 31, 2024
Accrued expenses and other current liabilities$16.5 $12.0 
Other liabilities1.8 2.0 
Total deferred revenue$18.3 $14.0 
Revenue recognized from amounts included in deferred revenue at the beginning of each respective period was as follows:
Nine Months Ended September 30,
(in millions)20252024
Deferred revenue recognized$10.3 $9.7 
Schedule of Contract Acquisition Costs
Contract acquisition costs, representing capitalized commission costs related to new customers, net of amortization, were included in the following consolidated balance sheet captions in the amounts shown:
(in millions)September 30, 2025December 31, 2024
Prepaid expenses and other current assets$24.3 $20.1 
Other assets50.8 40.8 
Total capitalized contract acquisition costs, net$75.1 $60.9